Metraipolis › archive › dc_4cee02ee1e04

The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches — Europe PMC PMID:41515914

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41515914
DOI
10.3390/ijms27010034
License (as archived)
solo-consultazione
Archived
2026-11-07T12:57:36.771Z
SHA-256 of the archived text
1f06f8770a9b7861a6d89008faffa71aa1ecbeb78e233e38703515e6565f6539
Stable URL of this page
https://metraipolis.com/documento/dc_4cee02ee1e04

How to cite

The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches — Europe PMC PMID:41515914 — Europe PMC (en), https://europepmc.org/article/MED/41515914 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4cee02ee1e04 (Metraipolis archive dc_4cee02ee1e04, sha256 1f06f8770a9b7861a6d89008faffa71aa1ecbeb78e233e38703515e6565f6539)
BibTeX
@misc{dc4cee02ee1e04,
  title = {The CTDP1 Founder Variant in CCFDN: Insights into Pathogenesis, Phenotypic Spectrum and Therapeutic Approaches — Europe PMC PMID:41515914},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41515914},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4cee02ee1e04; sha256 1f06f8770a9b7861a6d89008faffa71aa1ecbeb78e233e38703515e6565f6539},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41515914. Agents can read the archived copy with the MCP tool read_document.